Up next:
You are about to leave EKTERLY.com
You will be redirected to a third-party website
not affiliated with KalVista Pharmaceuticals.
This website is intended for US residents.
See how EKTERLY made a difference for people with hereditary angioedema (HAE).
Meet Cari, a mom of two and a physical therapist living with HAE. Hear about her journey from diagnosis to taking EKTERLY, and how it has changed her life to treat attacks with an on-demand oral medication.
For me, being able to stop the progression of an attack with an oral, on-demand medication has been a game-changer.
Individual results may vary. Patient has been compensated for her time.
EKTERLY is a prescription medicine used to treat sudden (acute) attacks of hereditary angioedema (HAE) in adults and children aged 12 years of age and older. It is not known if EKTERLY is safe and effective in children under 12 years of age.
Before taking EKTERLY, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking EKTERLY with certain other medicines can cause side effects or affect how well EKTERLY or the other medicines work. Especially tell your healthcare provider if you take any of the following, as their use with EKTERLY is not recommended: itraconazole, phenytoin, efavirenz.
Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
The most common side effects of EKTERLY include headache. For more information, ask your healthcare provider or pharmacist. Talk to your doctor for medical advice about side effects.
You are encouraged to report side effects related to KalVista products by calling 1-855-258-4782. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information, including Patient Information.